Note from the Editor
This interview is part of a series focusing on early career researchers and our Young Ambassador panel. You can read more at www.tandfonline.com/page/journal/fso/ambassadors.
Disclaimer
The opinions expressed in this interview are those of the interviewee and do not necessarily reflect the views of Future Science Ltd.
Financial & competing interests disclosure
E Anastasopoulou has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.
Additional information
Notes on contributors
Eleftheria A Anastasopoulou
Eleftheria Anastasopoulou speaks to Francesca Lake, Managing Editor: Eleftheria is currently pursuing her PhD in immunotherapy of cancer and biomarkers. Her interests focus mainly on detection of tumor antogen-specific T cells in vaccinated patients. She attained her degree at the National and Kapodistrian University of Athens, and holds an MSc from Leiden University.